BioSmart Co.Ltd (038460) — Capital Reinvestment Ratio
Latest as of September 2025:
0.16x
BioSmart Co.Ltd (038460) has a Capital Reinvestment Ratio of 0.16x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩7.59 Billion) in capital expenditures (₩1.22 Billion). See 038460 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.16x
Capex / Operating Cash Flow
Operating Cash Flow
₩7.59 Billion
KRW
Capital Expenditures
₩1.22 Billion
KRW
Data as of
Sep 2025
Most recent filing
BioSmart Co.Ltd Capital Reinvestment Ratio (2010–2024)
This chart tracks BioSmart Co.Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for BioSmart Co.Ltd (2010–2024)
Year-by-year Capital Reinvestment Ratio for BioSmart Co.Ltd from 2010 to 2024. For live market cap and broader valuation context, see how much is BioSmart Co.Ltd worth.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.28x | ₩3.80 Billion | ₩8.66 Billion | ▼ -45.9% |
| 2023 | 4.22x | ₩1.17 Billion | ₩4.92 Billion | ▲ +301.7% |
| 2022 | 1.05x | ₩5.59 Billion | ₩5.87 Billion | ▼ -75.8% |
| 2021 | 4.34x | ₩1.20 Billion | ₩5.22 Billion | ▲ +656.0% |
| 2018 | 0.57x | ₩5.81 Billion | ₩3.34 Billion | ▼ -19.1% |
| 2014 | 0.71x | ₩1.31 Billion | ₩927.27 Million | ▲ +265.3% |
| 2013 | 0.19x | ₩3.85 Billion | ₩748.17 Million | ▲ +87.0% |
| 2012 | 0.10x | ₩8.62 Billion | ₩895.45 Million | ▼ -16.0% |
| 2010 | 0.12x | ₩4.76 Billion | ₩589.05 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow